Achelios Therapeutics , Inc. logo

Achelios Therapeutics , Inc.

Achelios Therapeutics, is a specialty pharmaceutical company developing New Therapeutic Entities for the treatment of acute migraine and inflammation, by topically delivered medications.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://achelios.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
4364 S. Alston Avenue, Suite 300, Durham, 27713
North Carolina
United States
Email
Contact Number
+1 919-354-6233

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/achelios-therapeutics” connections=”true” suffix=””]

Achelioss proprietary drug delivery platform ACHETOGEL_ is a gel-based formulation (that can be modified readily to create liquid sprays as well) that enables superior transdermal penetration of active ingredients to the target tissue. ACHETOGEL _ is comprised of generally regarded as safe (GRAS) compounds, and is a biodegradable formulation. Furthermore, the formulation is thermodynamically stable, resistant to microbial contamination, and insensitive to moisture.